Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal

The World Health Organization (WHO) recommends that the cost-effectiveness (CE) of introducing new vaccines be considered before such a programme is implemented. However, in low- and middle-income countries (LMICs), it is often challenging to perform and interpret the results of model-based economic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutubessy, Raymond, Henao, Ana Maria, Namgyal, Pem, Moorthy, Vasee, Hombach, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117725/
https://www.ncbi.nlm.nih.gov/pubmed/21569407
http://dx.doi.org/10.1186/1741-7015-9-55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117725/
https://www.ncbi.nlm.nih.gov/pubmed/21569407
http://dx.doi.org/10.1186/1741-7015-9-55

Ejemplares similares